drugset / Trial / NCT00857649
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to examine the efficacy of memantine on cognition and behavioural symptoms in outpatients with moderate to severe dementia of the Alzheimer's type.
Timeline
- Start
- 2003-12
- Primary completion
- 2010-04
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 20 mg | Oral |